CareTrust REIT (NYSE:CTRE) Releases FY 2026 Earnings Guidance

Key Points

• CareTrust REIT raised its FY 2026 EPS guidance to $2.060–$2.090, up from its previously stated range of $2.030–$2.060. Analysts currently expect $2.04 in annual EPS.
• The company declared a quarterly dividend of $0.39 per share, equivalent to $1.56 annually and a 4.3% yield, though its payout ratio is high at 98.11%.
• Shares were trading down 1.8% at $35.91, while analysts maintained a generally positive outlook: the stock has a “Moderate Buy” consensus rating and a $44.50 average price target.

CareTrust REIT (NYSE:CTRE - Get Free Report) issued an update on its FY 2026 earnings guidance on Friday. The company provided earnings per share guidance of 2.060-2.090 for the period. The company issued revenue guidance of -.

CareTrust REIT Trading Down 1.8%

NYSE CTRE opened at $35.91 on Friday. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.57 and a current ratio of 0.57. The firm has a market cap of $8.48 billion, a PE ratio of 22.58, a P/E/G ratio of 1.45 and a beta of 0.75. CareTrust REIT has a one year low of $32.79 and a one year high of $43.62. The firm's fifty day moving average is $39.37 and its two-hundred day moving average is $39.46.

CareTrust REIT (NYSE:CTRE - Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported $0.51 EPS for the quarter, meeting analysts' consensus estimates of $0.51. CareTrust REIT had a net margin of 62.19% and a return on equity of 8.52%. The business had revenue of $161.35 million during the quarter. CareTrust REIT has set its FY 2026 guidance at 2.030-2.060 EPS. Analysts expect that CareTrust REIT will post 2.04 earnings per share for the current year.

CareTrust REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Wednesday, September 30th will be given a dividend of $0.39 per share. This represents a $1.56 dividend on an annualized basis and a yield of 4.3%. The ex-dividend date of this dividend is Wednesday, September 30th. CareTrust REIT's dividend payout ratio (DPR) is presently 98.11%.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on the company. KeyCorp reissued an "overweight" rating on shares of CareTrust REIT in a report on Wednesday, September 16th. Cantor Fitzgerald increased their price target on CareTrust REIT from $42.00 to $43.00 and gave the stock a "neutral" rating in a report on Monday, August 10th. Wells Fargo & Company lowered their price objective on shares of CareTrust REIT from $47.00 to $44.00 and set an "overweight" rating on the stock in a research report on Tuesday, September 1st. Weiss Ratings raised shares of CareTrust REIT from a "buy (b)" rating to a "buy (b+)" rating in a research note on Friday, September 25th. Finally, Citigroup restated a "market outperform" rating on shares of CareTrust REIT in a research report on Wednesday, June 10th. One investment analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and three have assigned a Hold rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $44.50.

CareTrust REIT Company Profile

CareTrust REIT, Inc is a real estate investment trust that owns, acquires, develops, and leases healthcare-related properties. Its portfolio is primarily focused on skilled nursing facilities, assisted living communities, and other post-acute care properties operated by third-party healthcare providers.

The company generally leases its properties under long-term agreements, including triple-net leases, under which tenants are typically responsible for property-level expenses such as taxes, insurance, and maintenance.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.